Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients.
Evy YunihastutiBramantya WicaksanaAndrian WiragunaAinum Jhariah HidayahFhadilla AmeliaVeritea NataliAlvina WidhaniAndri Sanityoso SulaimanJuferdy KurniawanPublished in: BMC infectious diseases (2020)
APRI score ≥ 1 and FIB-4 score ≥ 1.66 had moderate performance with high specificity in diagnosing cirrhosis. These biochemical markers could be used while TE is not available.